Wellington Management Group LLP Edwards Lifesciences Corp Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 33,210,879 shares of EW stock, worth $2.51 Billion. This represents 0.46% of its overall portfolio holdings.

Number of Shares

33,210,879

Previous 31,532,725 5.32%

Holding current value

$2.51 Billion

Previous $2.08 Billion 18.15%

% of portfolio

0.46%

Previous 0.37%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$64.54 - $75.92 $108 Million - $127 Million	1,678,154 Added 5.32%	33,210,879 $2.46 Billion
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $872 Million - $1.37 Billion	14,610,123 Added 86.33%	31,532,725 $2.08 Billion
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $116 Million - $129 Million	1,372,843 Added 8.83%	16,922,602 $1.56 Billion
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $1.13 Billion - $1.49 Billion	15,549,759 New	15,549,759 $1.49 Billion
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $1.04 Billion - $1.31 Billion	16,827,510 New	16,827,510 $1.28 Billion
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $96.3 Million - $130 Million	1,390,427 Added 9.24%	16,434,401 $1.14 Billion
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $65.6 Million - $76 Million	-806,081 Reduced 5.09%	15,043,974 $1.42 Billion
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $42.9 Million - $48.9 Million	578,319 Added 3.79%	15,850,055 $1.31 Billion
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $42.7 Million - $54.6 Million	624,619 Added 4.26%	15,271,736 $1.14 Billion
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $38.6 Million - $50.2 Million	468,181 Added 3.3%	14,647,117 $1.21 Billion
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $70.5 Million - $104 Million	-814,587 Reduced 5.43%	14,178,936 $1.35 Billion
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $61.8 Million - $77.8 Million	-606,517 Reduced 3.89%	14,993,523 $1.77 Billion
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $84 Million - $103 Million	-789,362 Reduced 4.82%	15,600,040 $2.02 Billion
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $36.5 Million - $43.6 Million	-354,990 Reduced 2.12%	16,389,402 $1.86 Billion
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $17.8 Million - $22.3 Million	212,898 Added 1.29%	16,744,392 $1.73 Billion
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $138 Million - $159 Million	-1,755,608 Reduced 9.6%	16,531,494 $1.38 Billion
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $139 Million - $177 Million	-1,940,078 Reduced 9.59%	18,287,102 $1.67 Billion
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $28.3 Million - $36.8 Million	-420,570 Reduced 2.04%	20,227,180 $1.61 Billion
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $820 Million - $1.1 Billion	14,243,532 Added 222.41%	20,647,750 $1.43 Billion
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $102 Million - $157 Million	1,940,741 Added 43.48%	6,404,218 $1.21 Billion
Q4 2019 Feb 11, 2020	BUY	$71.7 - $82.09 $320 Million - $366 Million	4,463,477 New	4,463,477 $1.04 Billion

Others Institutions Holding EW

# of Institutions

1,377

Shares Held

485M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Edwards Lifesciences Corp Transaction History